Fezolinetant
1 NDC across 1 manufacturer|0 Generic,1 Brand
Fezolinetant is used to treat hot flashes, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 12, 2023. In 2024, Medicare Part D spent $38 million on Fezolinetant across 53,000 claims for 14,000 beneficiaries.
Fezolinetant is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $18.59 to $18.59 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$18.59 – $18.59
per EA
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing FEZOLINETANT
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VEOZAH 45 MG TABLET | $18.5850 per EA | -0.02% |
Frequently Asked Questions
What is Fezolinetant used to treat?
Fezolinetant is used to treat hot flashes, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Fezolinetant?
In 2024, Medicare Part D spent $38 million on Fezolinetant across 53,000 claims for 14,000 beneficiaries.
How many Fezolinetant products are on the market?
The Fezolinetant drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Fezolinetant?
NADAC reference prices for Fezolinetant range from $18.5850 to $18.5850 per EA.
Which manufacturers make Fezolinetant?
1 manufacturer lists Fezolinetant in NADAC. Ranked by number of NDCs, the largest are Astellas Pharma US, Inc. (1).
How has the price of Fezolinetant changed recently?
Over the past 7 days, 0 Fezolinetant NDCs rose and 1 fell, with a market-wide average change of -0.0%.